Expro Group XPRO
$11.62 −$0.71 (-5.76%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.62 0.00%
Open$12.11
Prev close$12.33
Day range$11.53 – $12.22
Volume871.2K
Market cap$1.30B
P/E (TTM)1,162.0
Dividend yield–
XPRO Stock News
Headlines matching Expro Group or the XPRO ticker, most recent first.
- Barclays Maintains Expro Group(XPRO.US) With Buy Rating, Cuts Target Price to $19 Negative
- Barclays Maintains Expro Group(XPRO.US) With Buy Rating, Cuts Target Price to $20 Negative
- Goldman Sachs Upgrades Expro Group(XPRO.US) to Buy Rating, Maintains Target Price $19 Positive
- Barclays Maintains Expro Group(XPRO.US) With Buy Rating, Maintains Target Price $23
- Barclays Maintains Expro Group(XPRO.US) With Buy Rating, Raises Target Price to $23 Positive
- Earnings Flash (XPRO) Expro Group Holdings N.V. Posts Q1 Adjusted EPS $0.09 per Share
- Freedom Capital Markets Downgrades Expro Group(XPRO.US) to Hold Rating, Raises Target Price to $16 Mixed
- Piper Sandler Maintains Expro Group(XPRO.US) With Sell Rating, Raises Target Price to $16 Positive
- Barclays Maintains Expro Group(XPRO.US) With Buy Rating, Raises Target Price to $21 Positive
- Freedom Capital Markets Maintains Expro Group(XPRO.US) With Hold Rating, Cuts Target Price to $15 Negative
- Barclays Downgrades Expro Group(XPRO.US) to Hold Rating, Cuts Target Price to $14 Negative
- INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer's Drug Research and Explore New Applications for XPro
- Goldman Sachs Maintains Expro Group(XPRO.US) With Buy Rating, Maintains Target Price $19
- Goldman Sachs Maintains Expro Group(XPRO.US) With Hold Rating, Raises Target Price to $19 Positive
- Freedom Capital Markets Initiates Expro Group(XPRO.US) With Buy Rating, Announces Target Price $15
No comments yet — be the first to weigh in on XPRO.
Sign in to join the discussion.